|
US30985A
(en)
|
|
1860-12-18 |
|
Thomas l |
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
US4965195A
(en)
|
1987-10-26 |
1990-10-23 |
Immunex Corp. |
Interleukin-7
|
|
US4968607A
(en)
|
1987-11-25 |
1990-11-06 |
Immunex Corporation |
Interleukin-1 receptors
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US6713610B1
(en)
|
1990-01-12 |
2004-03-30 |
Raju Kucherlapati |
Human antibodies derived from immunized xenomice
|
|
DE69133566T2
(de)
|
1990-01-12 |
2007-12-06 |
Amgen Fremont Inc. |
Bildung von xenogenen Antikörpern
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
WO1991018982A1
(en)
|
1990-06-05 |
1991-12-12 |
Immunex Corporation |
Type ii interleukin-1 receptors
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
KR100272077B1
(ko)
|
1990-08-29 |
2000-11-15 |
젠팜인터내셔날,인코포레이티드 |
이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
WO1992022646A1
(en)
|
1991-06-14 |
1992-12-23 |
Dnx Corp. |
Production of human hemoglobin in transgenic pigs
|
|
JPH06508880A
(ja)
|
1991-07-08 |
1994-10-06 |
ユニバーシティ オブ マサチューセッツ アット アムハースト |
サーモトロピック液晶セグメント化ブロックコポリマー
|
|
AU3178993A
(en)
|
1991-11-25 |
1993-06-28 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
|
WO1994002602A1
(en)
|
1992-07-24 |
1994-02-03 |
Cell Genesys, Inc. |
Generation of xenogeneic antibodies
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US6130364A
(en)
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
JP4312259B2
(ja)
|
1995-04-27 |
2009-08-12 |
アムジェン フレモント インク． |
免疫したゼノマウス（ＸｅｎｏＭｏｕｓｅ）に由来するヒト抗体
|
|
WO1997034631A1
(en)
|
1996-03-18 |
1997-09-25 |
Board Of Regents, The University Of Texas System |
Immunoglobin-like domains with increased half lives
|
|
DE69738539T2
(de)
|
1996-12-03 |
2009-03-26 |
Amgen Fremont Inc. |
Vollkommen humane Antikörper die EGFR binden
|
|
US6878687B1
(en)
|
1997-03-07 |
2005-04-12 |
Human Genome Sciences, Inc. |
Protein HMAAD57
|
|
WO1998039446A2
(en)
|
1997-03-07 |
1998-09-11 |
Human Genome Sciences, Inc. |
70 human secreted proteins
|
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
|
EP1090118A2
(en)
|
1998-06-26 |
2001-04-11 |
Incyte Pharmaceuticals, Inc. |
Human signal peptide-containing proteins
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
|
AUPQ873300A0
(en)
|
2000-07-12 |
2000-08-03 |
Medvet Science Pty. Ltd. |
A binding motif of a receptor (2)
|
|
DK1272647T3
(en)
|
2000-04-11 |
2014-12-15 |
Genentech Inc |
Multivalent antibodies and uses thereof
|
|
US7858094B2
(en)
|
2000-12-08 |
2010-12-28 |
Geneprint Corporation |
TREM-1 splice variant for use in modifying immune responses
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
CA2342376C
(en)
|
2001-03-20 |
2013-11-12 |
Marco Colonna |
A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
|
US8231878B2
(en)
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
|
ATE454137T1
(de)
|
2001-07-25 |
2010-01-15 |
Facet Biotech Corp |
Stabile lyophilisierte pharmazeutische formulierung des igg-antikörpers daclizumab
|
|
AU2002334997A1
(en)
|
2001-10-12 |
2003-04-22 |
Schering Corporation |
Use of bispecific antibodies to regulate immune responses
|
|
AU2003215761A1
(en)
|
2002-03-22 |
2003-10-08 |
Bioxell S.P.A. |
A novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
|
US7556926B2
(en)
|
2002-05-24 |
2009-07-07 |
Takeda Pharmaceuticals Company Ltd. |
Methods for screening insulin-sensitizing agents
|
|
US7388079B2
(en)
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
|
US20090010920A1
(en)
|
2003-03-03 |
2009-01-08 |
Xencor, Inc. |
Fc Variants Having Decreased Affinity for FcyRIIb
|
|
US9714282B2
(en)
|
2003-09-26 |
2017-07-25 |
Xencor, Inc. |
Optimized Fc variants and methods for their generation
|
|
GB0401730D0
(en)
|
2004-01-27 |
2004-03-03 |
Bioxell Spa |
Diagnosis method
|
|
HRP20110320T1
(hr)
*
|
2004-05-27 |
2011-05-31 |
Crucell Holland B.V. |
Molekule za vezanje koje mogu neutralizirati virus bjesnoće i njihova uporaba
|
|
US7700099B2
(en)
|
2005-02-14 |
2010-04-20 |
Merck & Co., Inc. |
Non-immunostimulatory antibody and compositions containing the same
|
|
US8101345B1
(en)
|
2005-03-25 |
2012-01-24 |
Isis Pharmaceuticals, Inc. |
Proinflammatory nucleic acids
|
|
KR20060135280A
(ko)
|
2005-06-24 |
2006-12-29 |
전남대학교산학협력단 |
선천성 면역에 관여하는 트렘-2의 클로닝
|
|
AU2006265113A1
(en)
|
2005-07-01 |
2007-01-11 |
The Johns Hopkins University |
Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
|
|
US20070041905A1
(en)
|
2005-08-19 |
2007-02-22 |
Hoffman Rebecca S |
Method of treating depression using a TNF-alpha antibody
|
|
US7951918B2
(en)
|
2006-03-17 |
2011-05-31 |
Biogen Idec Ma Inc. |
Stabilized polypeptide compositions
|
|
DE202006007499U1
(de)
|
2006-05-11 |
2007-01-11 |
Osaka University |
Verwendung einer Zusammensetzung, die Plexin-A1-DAP12-Interaktion inhibiert, zur Behandlung von Entzündungs-, Autoimmun- oder Knochenresorptionserkrankungen
|
|
CN105837690A
(zh)
|
2006-06-12 |
2016-08-10 |
新兴产品开发西雅图有限公司 |
具有效应功能的单链多价结合蛋白
|
|
CA2551163A1
(en)
|
2006-07-17 |
2008-01-17 |
Boehringer Ingelheim International Gmbh |
Methods for treating inflammatory, autoimmune or bone resorption diseases
|
|
US7553936B2
(en)
|
2006-12-04 |
2009-06-30 |
The United States of America as represented by Secretary Department of Health and Human Services |
Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions
|
|
WO2008088849A2
(en)
|
2007-01-16 |
2008-07-24 |
Wyeth |
Inflammation treatment, detection and monitoring via trem-1
|
|
RU2009137582A
(ru)
|
2007-03-12 |
2011-04-20 |
Эсбатек Аг (Ch) |
Инженерия и оптимизация одноцепочечных антител на основе последовательности
|
|
US8793074B2
(en)
|
2007-06-21 |
2014-07-29 |
Saint Louis University |
Sequence covariance networks, methods and uses therefor
|
|
BRPI0813645A2
(pt)
|
2007-06-25 |
2014-12-30 |
Esbatech Alcon Biomed Res Unit |
Métodos para modificar anticorpos, e anticorpos modificados com propriedades funcionais aperfeiçoadas
|
|
GR1007327B
(el)
|
2007-08-08 |
2011-06-27 |
Ευαγγελος Γιαμαρελλος-Μπουρμπουλης |
Ο διαλυτος υποδοχεας ενεργοποιησης των μυελοκυτταρων (strem-1) ως δεικτης αποτελεσματικοτητας της θεραπειας του πεπτικου ελκους
|
|
EP2197911A2
(en)
|
2007-09-14 |
2010-06-23 |
Amgen Inc. |
Homogeneous antibody populations
|
|
TW200918553A
(en)
*
|
2007-09-18 |
2009-05-01 |
Amgen Inc |
Human GM-CSF antigen binding proteins
|
|
PT2235064E
(pt)
|
2008-01-07 |
2016-03-01 |
Amgen Inc |
Método de preparação de moléculas heterodiméricas de fc de anticorpos utilizando efeitos de indução eletrostática
|
|
KR100960684B1
(ko)
|
2008-02-22 |
2010-05-31 |
전남대학교산학협력단 |
Ｇａ733-2 발현 억제제로서의 ｔｒｅｍ-2 유전자, 및 이를포함하는 형질전환 동물 및 이의 사용방법
|
|
US20110256213A1
(en)
|
2008-10-15 |
2011-10-20 |
The Board Of Trustees Of The University Of Illinois |
Phospholipid micellar and liposomal compositions and uses thereof
|
|
EP2424977B1
(en)
|
2009-04-28 |
2013-06-12 |
Life & Brain GmbH |
Microglial precursor cells for the treatment of malignant neoplasms of the central nervous system
|
|
WO2010132370A2
(en)
|
2009-05-11 |
2010-11-18 |
Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Soluble tlt-1 for the treatment and diagnosis of sepsis
|
|
US20120213705A1
(en)
|
2009-06-22 |
2012-08-23 |
Medimmune, Llc |
ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION
|
|
WO2011047097A2
(en)
|
2009-10-13 |
2011-04-21 |
Sigalov Alexander B |
Inhibition of trem receptor signaling with peptide variants
|
|
CN102038698A
(zh)
|
2009-10-14 |
2011-05-04 |
山东绿叶天然药物研究开发有限公司 |
莫诺苷的新用途
|
|
JO3244B1
(ar)
*
|
2009-10-26 |
2018-03-08 |
Amgen Inc |
بروتينات ربط مستضادات il – 23 البشرية
|
|
US20120316071A1
(en)
*
|
2009-11-04 |
2012-12-13 |
Vaughn Smider |
Methods for affinity maturation-based antibody optimization
|
|
CN102127168A
(zh)
|
2010-01-19 |
2011-07-20 |
中国人民解放军第二军医大学 |
一种髓样细胞表达激发受体-1的重组融合蛋白及其应用
|
|
KR20110086460A
(ko)
|
2010-01-22 |
2011-07-28 |
한국교원대학교산학협력단 |
수용성 수용체 라이브러리 및 이를 이용한 사이토카인 발현 조절 유전자의 스크리닝 방법
|
|
DK2555789T3
(da)
|
2010-04-08 |
2020-07-20 |
Inst Nat Sante Rech Med |
Hæmmende peptider afledt af trem-lignende transcript 1 (tlt-1) og anvendelser deraf
|
|
CA2798120A1
(en)
|
2010-04-30 |
2011-11-03 |
Paul P. Tamburini |
Antibodies having reduced immunogenicity in a human
|
|
WO2012016333A1
(en)
|
2010-08-06 |
2012-02-09 |
University Health Network |
Biomarkers for malaria
|
|
US20130130354A1
(en)
|
2010-09-28 |
2013-05-23 |
CTI Salud S.A. |
Novel genes and uses thereof, expression profile of colon, gastric and pancreatic cancer
|
|
WO2012088290A2
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Tri-variable domain binding proteins and uses thereof
|
|
WO2012088302A2
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Half immunoglobulin binding proteins and uses thereof
|
|
US10689447B2
(en)
|
2011-02-04 |
2020-06-23 |
Genentech, Inc. |
Fc variants and methods for their production
|
|
EP2686682A4
(en)
|
2011-03-11 |
2015-03-11 |
Amgen Inc |
METHOD FOR CORRELATED MUTATION ANALYSIS TO IMPROVE THERAPEUTIC ANTIBODIES
|
|
KR20120112973A
(ko)
|
2011-04-04 |
2012-10-12 |
전남대학교산학협력단 |
비만 또는 제 2형 당뇨의 예방 또는 치료용 조성물
|
|
US20130058947A1
(en)
|
2011-09-02 |
2013-03-07 |
Stem Centrx, Inc |
Novel Modulators and Methods of Use
|
|
ES2971444T3
(es)
|
2011-10-11 |
2024-06-05 |
F Hoffmann Lar Roche Ag |
Ensamblaje mejorado de anticuerpos biespecíficos
|
|
KR20190077124A
(ko)
|
2011-10-21 |
2019-07-02 |
스템제닉스 인코포레이티드 |
생물학적 활성 분자의 세포내 전달을 위한 작용화 나노입자
|
|
KR102052774B1
(ko)
|
2011-11-04 |
2019-12-04 |
자임워크스 인코포레이티드 |
Ｆｃ 도메인 내의 돌연변이를 갖는 안정한 이종이합체 항체 설계
|
|
ES2749349T3
(es)
|
2011-11-07 |
2020-03-19 |
Medimmune Llc |
Proteínas de unión multiespecíficas y multivalentes y usos de las mismas
|
|
WO2013093809A1
(en)
|
2011-12-23 |
2013-06-27 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
|
TWI450727B
(zh)
|
2011-12-29 |
2014-09-01 |
Ind Tech Res Inst |
抗人類輸鐵蛋白受體的單域抗體與其應用
|
|
CN102517287B
(zh)
|
2012-01-10 |
2013-09-11 |
广西大学 |
抑制水牛TREM1基因表达的shRNA、慢病毒表达载体及其构建方法和应用
|
|
KR20130114951A
(ko)
|
2012-04-10 |
2013-10-21 |
한양대학교 산학협력단 |
폴리감마글루탐산을 포함하는 Ｔｈ17 매개성 질환 예방 또는 치료용 조성물
|
|
ES2797625T3
(es)
|
2012-09-07 |
2020-12-03 |
Inst Nat Sante Rech Med |
Péptidos inhibitorios derivados del receptor desencadenante expresado en células mieloides-1 (TREM-1) y del transcrito similar a TREM 1 (TLT-1) y sus usos
|
|
JP6461800B2
(ja)
|
2012-10-04 |
2019-01-30 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
ヒトモノクローナル抗ｐｄ−ｌ１抗体および使用方法
|
|
WO2014065945A1
(en)
|
2012-10-23 |
2014-05-01 |
The Board Of Regents Of The University Of Texas System |
Antibodies with engineered igg fc domains
|
|
WO2014074942A1
(en)
|
2012-11-08 |
2014-05-15 |
Illumina, Inc. |
Risk variants of alzheimer's disease
|
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
US9066928B1
(en)
*
|
2012-12-04 |
2015-06-30 |
University Of Kentucky Research Foundation |
Method, composition, and kit useful for treatment of alzheimer's disease
|
|
US9546203B2
(en)
|
2013-03-14 |
2017-01-17 |
Amgen Inc. |
Aglycosylated Fc-containing polypeptides with cysteine substitutions
|
|
EP4324480A3
(en)
|
2013-05-20 |
2024-05-08 |
F. Hoffmann-La Roche AG |
Anti-transferrin receptor antibodies and methods of use
|
|
KR20150010326A
(ko)
|
2013-07-19 |
2015-01-28 |
전남대학교산학협력단 |
비만 및 제 2형 당뇨 또는 지방간의 예방 또는 치료용 바이아릴아마이드를 포함한 유도체 화합물
|
|
KR101402921B1
(ko)
|
2013-08-28 |
2014-06-02 |
전남대학교산학협력단 |
비만 또는 제 2형 당뇨의 치료를 위한 레스베라톨 유도체의 이용
|
|
CA2825821A1
(en)
|
2013-08-28 |
2015-02-28 |
Chiesi Farmaceutici S.P.A. |
1-phenylalkanecarboxylic acid derivatives for the treatment of alzheimer's disease and multiple sclerosis
|
|
WO2015037000A1
(en)
|
2013-09-11 |
2015-03-19 |
Compugen Ltd |
Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, infectious diseases and immune related diseases
|
|
CN103555829B
(zh)
|
2013-10-12 |
2015-10-21 |
厦门人瑞生物医药科技有限公司 |
一种检测trem2基因r47h突变的探针、试剂盒和方法
|
|
CA2936056A1
(en)
|
2014-01-06 |
2015-07-09 |
Children's Medical Center Corporation |
Biomarkers for dementia and dementia related neurological disorders
|
|
JOP20200096A1
(ar)
|
2014-01-31 |
2017-06-16 |
Children’S Medical Center Corp |
جزيئات جسم مضاد لـ tim-3 واستخداماتها
|
|
CN103866041A
(zh)
|
2014-04-04 |
2014-06-18 |
厦门大学 |
帕金森病和脑白质疏松症的突变检测试剂盒及其检测方法
|
|
PT3129406T
(pt)
|
2014-04-11 |
2019-04-24 |
Medimmune Llc |
Compostos conjugados que compreendem anticorpos com manipulação de cisteínas
|
|
CN105218669A
(zh)
|
2014-06-10 |
2016-01-06 |
河北翰林生物科技有限公司 |
制备抗人r47h-trem2突变体的人单克隆抗体的方法
|
|
US20170218091A1
(en)
|
2014-07-03 |
2017-08-03 |
Abbvie Inc. |
Monovalent binding proteins
|
|
KR20250110365A
(ko)
|
2014-07-17 |
2025-07-18 |
노보 노르디스크 에이/에스 |
점도를 감소시키기 위한 trem-1 항체의 부위 지정 돌연변이유발
|
|
SG11201700901SA
(en)
|
2014-08-08 |
2017-03-30 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
KR101756417B1
(ko)
|
2014-08-21 |
2017-07-10 |
한국유나이티드제약 주식회사 |
금제제를 포함하는 간 섬유화 또는 간 경화의 예방 또는 치료용 약학적 조성물
|
|
CN106999585A
(zh)
|
2014-09-28 |
2017-08-01 |
加利福尼亚大学董事会 |
对刺激性和非刺激性骨髓细胞的调节
|
|
WO2016064895A1
(en)
|
2014-10-20 |
2016-04-28 |
The Brigham And Women's Hospital, Inc. |
Targeting apolipoprotein e (apoe) in neurologic disease
|
|
US10081792B2
(en)
|
2014-12-31 |
2018-09-25 |
Wisconsin Alumni Research Foundation |
Derivation of human microglia from pluripotent stem cells
|
|
EP3283508B1
(en)
|
2015-04-17 |
2021-03-17 |
Alpine Immune Sciences, Inc. |
Immunomodulatory proteins with tunable affinities
|
|
WO2016187339A1
(en)
|
2015-05-18 |
2016-11-24 |
Synaptec Development Llc |
GALANTAMINE CLEARANCE OF AMYLOIDß
|
|
CN107922480B
(zh)
|
2015-06-12 |
2022-09-23 |
艾利妥 |
抗cd33抗体及其使用方法
|
|
HK1252675A1
(zh)
|
2015-06-12 |
2019-05-31 |
Alector Llc |
抗cd33抗体及其使用方法
|
|
US10765679B2
(en)
|
2015-07-04 |
2020-09-08 |
Emory University |
Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 infection
|
|
US20180194861A1
(en)
|
2015-07-10 |
2018-07-12 |
Abbvie Inc. |
IgM- or IgE-Modified Binding Proteins and Uses Thereof
|
|
CN116333138A
(zh)
|
2015-07-30 |
2023-06-27 |
宏观基因有限公司 |
Pd-1结合分子和其使用方法
|
|
JP7525980B2
(ja)
|
2015-08-28 |
2024-07-31 |
アレクトル エルエルシー |
抗Ｓｉｇｌｅｃ－７抗体及びその使用方法
|
|
WO2017058866A1
(en)
|
2015-09-28 |
2017-04-06 |
Precision Immune, Inc. |
Anti-trem2 antibodies and uses thereof
|
|
JP7725185B2
(ja)
*
|
2015-10-06 |
2025-08-19 |
アレクトル エルエルシー |
抗ｔｒｅｍ２抗体及びその使用方法
|
|
JP7060502B2
(ja)
|
2015-10-29 |
2022-04-26 |
アレクトル エルエルシー |
抗Ｓｉｇｌｅｃ－９抗体及びその使用方法
|
|
US20170218058A1
(en)
|
2016-01-28 |
2017-08-03 |
Alector, LLC |
Anti-apoe4 antigen-binding proteins and methods of use thereof
|
|
US12156890B2
(en)
|
2016-02-11 |
2024-12-03 |
The Johns Hopkins University |
Compositions and methods for neuralgenesis
|
|
US11066456B2
(en)
|
2016-02-25 |
2021-07-20 |
Washington University |
Compositions comprising TREM2 and methods of use thereof
|
|
US11472877B2
(en)
|
2016-03-04 |
2022-10-18 |
Alector Llc |
Anti-TREM1 antibodies and methods of use thereof
|
|
US10875919B2
(en)
|
2016-04-26 |
2020-12-29 |
Alector Llc |
Chimeric receptors and methods of use thereof
|
|
EP3452101A2
(en)
|
2016-05-04 |
2019-03-13 |
CureVac AG |
Rna encoding a therapeutic protein
|
|
AU2017273629B2
(en)
|
2016-06-01 |
2023-06-08 |
The University Of Virginia Patent Foundation |
Methods and compositions for modulating lymphatic vessels in the central nervous system
|
|
JP2019531332A
(ja)
|
2016-07-22 |
2019-10-31 |
ドイチェス ツェントルム フュール ノイロデゲネラティフェ アークランクンゲン エー．ファウ．（デーツェットエンエー） |
Ｔｒｅｍ２切断モジュレーター及びその使用
|
|
CN106244682B
(zh)
|
2016-07-29 |
2019-11-26 |
中山大学 |
Trem-2基因在鉴别猪对蓝耳病毒易感性中的应用
|
|
CN106636330B
(zh)
|
2016-09-21 |
2017-12-15 |
郁金泰 |
阿尔茨海默病的诊断和治疗药物
|
|
CA3040687A1
(en)
|
2016-10-14 |
2018-04-19 |
Childrens' Medical Center Corporation |
Compositions and methods for treating diseases and disorders of the central nervous system
|
|
JP7173971B2
(ja)
|
2016-12-09 |
2022-11-16 |
アレクトル エルエルシー |
抗ＳＩＲＰ－α抗体及びその使用方法
|
|
CN110381981A
(zh)
|
2016-12-23 |
2019-10-25 |
健能万生物制药公司 |
在诊断和治疗阿尔茨海默病中使用gm6的方法
|
|
WO2018132728A1
(en)
|
2017-01-12 |
2018-07-19 |
Duke University |
Compositions and methods for the treatment of demyelinating conditions
|
|
WO2018134815A2
(en)
|
2017-01-17 |
2018-07-26 |
Yeda Research And Development Co. Ltd. |
Methods of treating neurodegenerative diseases by inducing disease-associated microglia (dam) cells
|
|
WO2018136598A1
(en)
|
2017-01-18 |
2018-07-26 |
Evelo Biosciences, Inc. |
Methods of treating cancer
|
|
WO2018140831A2
(en)
|
2017-01-27 |
2018-08-02 |
Silverback Therapeutics, Inc. |
Tumor targeting conjugates and methods of use thereof
|
|
US10143187B2
(en)
|
2017-02-17 |
2018-12-04 |
Denali Therapeutics Inc. |
Transferrin receptor transgenic models
|
|
US20210293794A1
(en)
|
2017-02-24 |
2021-09-23 |
University Of Hawii Cancer Center |
Metabolic biomarkers for the identification and characterization of alzheimers disease
|
|
US20200239844A1
(en)
|
2017-02-28 |
2020-07-30 |
The Regents Of The University Of California |
Differentiation and use of human microglia-like cells from pluripotent stem cells and hematopoietic progenitors
|
|
WO2018175581A1
(en)
|
2017-03-21 |
2018-09-27 |
The Jackson Laboratory |
A GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 MOUSE Trem2.p.R47H AND METHODS OF USE THEREOF
|
|
KR101936249B1
(ko)
|
2017-04-04 |
2019-01-08 |
경희대학교 산학협력단 |
쿠마타케닌을 포함하는 암의 예방, 개선 또는 치료용 조성물
|
|
JOP20190248A1
(ar)
|
2017-04-21 |
2019-10-20 |
Amgen Inc |
بروتينات ربط مولد ضد trem2 واستخداماته
|
|
US20180318379A1
(en)
|
2017-05-01 |
2018-11-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Inhibition of triggering receptor expressed on myeloid cells 1 (trem1) to treat central nervous system disorders
|
|
US11359014B2
(en)
|
2017-05-16 |
2022-06-14 |
Alector Llc |
Anti-siglec-5 antibodies and methods of use thereof
|
|
US20180340945A1
(en)
|
2017-05-24 |
2018-11-29 |
Nanosomix, Inc. |
Detection of biomarkers on vesicles for the diagnosis and prognosis of diseases and disorders
|
|
BR112019025583A2
(pt)
|
2017-06-05 |
2020-06-16 |
Janssen Biotech, Inc. |
Anticorpos multiespecíficos geneticamente modificados e outras proteínas multiméricas com mutações assimétricas na região ch2-ch3
|
|
CN111148761B
(zh)
|
2017-06-25 |
2024-02-13 |
西雅图免疫公司 |
多特异性抗体及其制备和使用方法
|
|
US20190008812A1
(en)
|
2017-07-07 |
2019-01-10 |
Washington University |
Methods for treating microglial dysfunction
|
|
CN109206503A
(zh)
|
2017-07-07 |
2019-01-15 |
厦门大学 |
一种蛋白用于制备防治阿尔茨海默病药物的用途
|
|
WO2019016784A1
(en)
|
2017-07-21 |
2019-01-24 |
Universidade De Coimbra |
ANTI-NUCLEOLIN ANTIBODIES
|
|
BR112020001060A2
(pt)
|
2017-07-27 |
2020-07-14 |
Novartis Ag |
variantes de trem2 resistentes a shedase
|
|
PE20200486A1
(es)
|
2017-08-03 |
2020-03-03 |
Alector Llc |
Anticuerpos anti-cd33 y metodos para utilizarlos
|
|
HRP20230675T1
(hr)
|
2017-08-03 |
2023-09-29 |
Alector Llc |
Anti-trem2 protutijela i postupci njihove uporabe
|
|
EP3664845A4
(en)
|
2017-08-08 |
2021-03-10 |
Pionyr Immunotherapeutics, Inc. |
COMPOSITIONS AND METHODS FOR DEACTIVATING MEYLOID CELLS EXPRESSING TREM1
|
|
CA3075285A1
(en)
|
2017-09-14 |
2019-03-21 |
Denali Therapeutics Inc. |
Anti-trem2 antibodies and methods of use thereof
|
|
US12276670B2
(en)
|
2017-09-29 |
2025-04-15 |
The General Hospital Corporation |
Methods for identifying and treating adrenomyeloneuropathy (AMN)
|
|
US11364303B2
(en)
|
2017-09-29 |
2022-06-21 |
Pfizer Inc. |
Cysteine engineered antibody drug conjugates
|
|
BR112020006661A2
(pt)
|
2017-10-03 |
2020-10-13 |
Prevail Therapeutics, Inc. |
terapias de genes para distúrbios lipossomais
|
|
WO2019079529A1
(en)
|
2017-10-17 |
2019-04-25 |
The Translational Genomics Research Institute |
TREM2 AGONISTS FOR STIMULATING MICROGLIA AND IDENTIFICATION METHODS
|
|
US10597462B1
(en)
|
2017-11-08 |
2020-03-24 |
University Of Puerto Rico |
Anti-TLT-1 antibody and uses thereof
|
|
EP3710015B1
(en)
|
2017-11-15 |
2024-01-17 |
Université Laval |
Use of srsf3 agents for the treatment and/or prevention of neurological conditions, cancer, bacterial infections or viral infections
|
|
CN109837330A
(zh)
|
2017-11-28 |
2019-06-04 |
上海中优精准医疗科技股份有限公司 |
一种检测trem2基因多态性的探针及方法
|
|
US11470827B2
(en)
|
2017-12-12 |
2022-10-18 |
Alector Llc |
Transgenic mice expressing human TREM proteins and methods of use thereof
|
|
CN111712258B
(zh)
|
2017-12-12 |
2024-03-15 |
开拓免疫医疗公司 |
抗trem2抗体和相关方法
|
|
EP3746476A1
(en)
|
2018-01-31 |
2020-12-09 |
Alector LLC |
Anti-ms4a4a antibodies and methods of use thereof
|
|
US12091455B2
(en)
|
2018-02-14 |
2024-09-17 |
Yale University |
Compositions for modulation of a TREM or TREML protein and methods of use
|
|
NL2020520B1
(en)
|
2018-03-02 |
2019-09-12 |
Labo Bio Medical Invest B V |
Multispecific binding molecules for the prevention, treatment and diagnosis of neurodegenerative disorders
|
|
US12201619B2
(en)
|
2018-03-22 |
2025-01-21 |
Nsc Therapeutics Gmbh |
Compounds and methods for use in the treatment of microglia-mediated disorders
|
|
CR20250022A
(es)
|
2018-04-02 |
2025-02-25 |
Bristol Myers Squibb Co |
Anticuerpos anti-trem-1, ácidos nucleicos y vectores de los mismos (divisional 2020-0450)
|
|
CN112912072A
(zh)
|
2018-04-09 |
2021-06-04 |
通用医疗公司 |
组合疗法治疗肌萎缩侧索硬化症及相关疾病
|
|
PE20210342A1
(es)
|
2018-05-25 |
2021-02-23 |
Alector Llc |
Anticuerpos anti-sirpa y metodos de utilizacion de los mismos
|
|
CN119841953A
(zh)
|
2018-06-08 |
2025-04-18 |
艾利妥 |
抗siglec-7抗体及其使用方法
|
|
CN108752482B
(zh)
|
2018-06-12 |
2019-04-30 |
南京卡提医学科技有限公司 |
携带截短或未截短的髓样细胞触发性受体信号结构的嵌合抗原受体及其应用
|
|
WO2019246483A1
(en)
|
2018-06-21 |
2019-12-26 |
The Jackson Laboratory |
Genetically modified mouse models of alzheimer's disease
|
|
US12060422B2
(en)
|
2018-06-29 |
2024-08-13 |
Alector Llc |
Anti-SIRP-Beta1 antibodies and methods of use thereof
|
|
US12174192B2
(en)
|
2018-07-12 |
2024-12-24 |
Corvus Pharmaceuticals, Inc. |
Methods for detecting and treating cancers having adenosine pathway activation
|
|
US11278575B2
(en)
|
2018-07-12 |
2022-03-22 |
Duke University |
Compositions and methods for the treatment of demyelinating conditions
|
|
WO2020018461A1
(en)
|
2018-07-16 |
2020-01-23 |
The University Of Virginia Patent Foundation |
Compositions and methods of diagnosis and treatment for neurological diseases
|
|
SG11202100555PA
(en)
|
2018-07-27 |
2021-02-25 |
Alector Llc |
Anti-siglec-5 antibodies and methods of use thereof
|
|
CN109112214A
(zh)
|
2018-07-27 |
2019-01-01 |
复旦大学附属中山医院 |
模式识别受体trem2在肝癌预后和治疗中的应用
|
|
BR112021003016A2
(pt)
|
2018-08-31 |
2021-05-18 |
Alector Llc |
anticorpos isolados, ácido nucleico isolado, vetor, célula hospedeira, métodos para produzir um anticorpo e para prevenir, reduzir o risco ou tratar uma doença e composição farmacêutica
|
|
JP2021535181A
(ja)
|
2018-09-05 |
2021-12-16 |
ザ ジェネラル ホスピタル コーポレイション |
サイトカイン放出症候群を処置する方法
|
|
CN113164572A
(zh)
|
2018-09-11 |
2021-07-23 |
华盛顿大学 |
抗trem-2激动剂抗体
|
|
WO2020056114A1
(en)
|
2018-09-12 |
2020-03-19 |
Board Of Regents Of The University Of Nebraska |
Antimicrobial compositions and methods
|
|
KR102831552B1
(ko)
|
2018-09-28 |
2025-07-08 |
이노트렘 |
항염 요법에 반응할 수 있는 대상체를 식별하기 위한 가용성 trem-1 수준의 용도
|
|
KR102096282B1
(ko)
|
2018-10-15 |
2020-04-02 |
재단법인대구경북과학기술원 |
재조합 베큘로바이러스를 이용한 인간 ｔｒｅｍ２ 세포막 단백질의 효율적인 정제방법
|
|
UY38407A
(es)
|
2018-10-15 |
2020-05-29 |
Novartis Ag |
Anticuerpos estabilizadores de trem2
|
|
KR102156165B1
(ko)
|
2018-10-29 |
2020-09-15 |
재단법인대구경북과학기술원 |
인간 ｔｒｅｍ２ 세포막 단백질에 대한 단일클론항체, 이를 생산하는 하이브리도마 세포주 및 이의 용도
|
|
CN111135185A
(zh)
|
2018-11-02 |
2020-05-12 |
杭州星鳌生物科技有限公司 |
天然免疫激活通过调控髓系细胞触发受体trem2抑制大脑神经慢性炎症
|
|
US12466892B2
(en)
|
2018-11-08 |
2025-11-11 |
The Regents Of The University Of California |
Systems and methods for targeting cancer cells
|
|
US20230132366A9
(en)
|
2018-11-26 |
2023-04-27 |
Denali Therapeutics Inc. |
Methods for treating dysregulated lipid metabolism
|
|
EP3898691A4
(en)
|
2018-12-10 |
2022-09-14 |
Mor Research Applications |
TREM2 ANTIBODIES AND THEIR USES
|
|
JP2022514290A
(ja)
|
2018-12-20 |
2022-02-10 |
ジェネンテック， インコーポレイテッド |
改変抗体ｆｃおよび使用方法
|
|
WO2020142659A2
(en)
|
2019-01-04 |
2020-07-09 |
Trio Pharmaceuticals, Inc. |
Multi-specific protein molecules and uses thereof
|
|
CN109646668B
(zh)
|
2019-01-04 |
2019-10-18 |
厦门大学 |
一种多肽用于制备防治阿尔茨海默病药物的用途
|
|
MA54752A
(fr)
|
2019-01-14 |
2021-11-24 |
Univ Virginia Patent Foundation |
Utilisation d'inhibiteurs d'intégrine pour le traitement ou la prévention d'un trouble immunitaire neurologique et/ou d'une lésion du système nerveux
|
|
WO2020152607A1
(en)
|
2019-01-22 |
2020-07-30 |
St. Jude Children's Research Hospital |
Modulation of lc3-associated endocytosis pathway and genetically modified non-human animals as a model of neuroinflammation and neurodegeneration
|
|
US20220099659A1
(en)
|
2019-01-23 |
2022-03-31 |
The Regents Of The University Of California |
Human Genomic Construct Reporter Cells and Mouse Models to Screen Therapeutics against Microglia-expressed Disease Associated Genes
|
|
WO2020160468A1
(en)
|
2019-02-01 |
2020-08-06 |
Avrobio, Inc. |
Compositions and methods for treating neurocognitive disorders
|
|
WO2020160217A1
(en)
|
2019-02-01 |
2020-08-06 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Microenvironment sensors to regulate engineered gene expression
|
|
US20220133850A1
(en)
|
2019-02-01 |
2022-05-05 |
Avrobio, Inc. |
Compositions and methods for treating neurocognitive disorders
|
|
AU2020226754A1
(en)
|
2019-02-20 |
2021-09-16 |
Denali Therapeutics Inc. |
Anti-TREM2 antibodies and methods of use thereof
|
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
|
CN110320368A
(zh)
|
2019-05-30 |
2019-10-11 |
广州医科大学附属第一医院（广州呼吸中心） |
基于trem2的诊断试剂盒及其在帕金森病诊断产品上的应用
|
|
CN110241208A
(zh)
|
2019-08-02 |
2019-09-17 |
辽宁中医药大学 |
Trem2作为早期诊断冠心病的分子标志物的应用
|
|
CN110511240B
(zh)
|
2019-08-27 |
2022-03-08 |
南京医科大学 |
一种髓细胞触发受体2的内源性配体及其应用
|
|
CN110882262A
(zh)
|
2019-11-06 |
2020-03-17 |
南京医科大学 |
一种髓细胞触发受体2的激活用药及其应用
|
|
PH12022551228A1
(en)
|
2019-11-22 |
2023-06-14 |
Lilly Co Eli |
Trem2 antibodies and uses thereof
|
|
US20230024528A1
(en)
|
2019-12-05 |
2023-01-26 |
Alector Llc |
Methods of use of anti-trem2 antibodies
|
|
CN111184742B
(zh)
|
2020-02-13 |
2022-06-24 |
中山大学附属第五医院 |
Trem-2+t细胞在制备用于治疗结核病药物中的应用
|